Otsuka Pharmaceutical Co., Ltd. v. JAMP Pharma Corporation
2023
T-1737-23
Pending
8.2 PMNOC
Actions under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,832,157 (brexpiprazole).
Counsel to:
JAMP Pharma Corporation
The decision is reported
here.
Meet the team
![Warren Sprigings](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0b602718f3580ecb0cc1e_warren-bw-min.jpg)
Warren Sprigings
Partner
![Meghan A. Dureen, Ph.D.](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5da0bae05e71cd3af89ae952_meghan-bw-min.jpeg)
Meghan A. Dureen, Ph.D.
Counsel
![Alexandre Lavoie](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/5f3588452d3c6c32143ccddb_alavoie.jpg)
Alexandre Lavoie
Associate
![Raenaud Tiwari](https://cdn.prod.website-files.com/5d9fc778718dbe2981337802/65a2febac0d90b9719700f08_Mask%20group-1.jpg)
Raenaud Tiwari
Associate